Page last updated: 2024-08-26

mizoribine and mocetinostat

mizoribine has been researched along with mocetinostat in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Hosono, S; Kato, K; Murakami, R; Muramatsu, M; Omote, A; Sano, H; Sugimoto, Y; Tanaka, H; Watanabe, Y1
Akimoto, T; Ando, Y; Asano, Y; Ito, C; Kusano, E1
Kawakami, T1
Chinda, J; Fujino, T; Hasebe, N; Kabara, M; Matsuki, M; Nakagawa, N1
Himeji, D; Kai, Y; Matsuda, M; Niiro, H; Ono, N; Oryoji, D; Ueda, A; Ueki, Y; Uezono, S; Yoshihiro, K1
Iwamura, C; Kameoka, Y; Kobayashi, S; Kusunoki, R; Nagao, T; Nakayama, T; Suzuki, K; Yumura, W1
Chen, KR; Kamioka, I; Kitagawa, C; Oka, M; Yamada, Y1
Awanami, Y; Fukuda, M; Fukunari, K; Ikeda, Y; Kanaya, A; Matsumoto, K; Miyazono, M; Takashima, T; Uchiumi, S1
Arimura, Y; Fujimoto, S; Hirawa, N; Ito, T; Kobayashi, M; Makino, H; Mase, K; Matsuo, S; Muso, E; Nakagawa, N; Nitta, K; Saito, C; Usui, J; Wada, T; Yamagata, K; Yumura, W; Yuzawa, Y1

Reviews

2 review(s) available for mizoribine and mocetinostat

ArticleYear
New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
    The Journal of dermatology, 2010, Volume: 37, Issue:2

    Topics: Adrenal Cortex Hormones; Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Clopidogrel; Cryoglobulinemia; Diagnosis, Differential; Humans; IgA Vasculitis; Immunoglobulin A; Myeloblastin; Peroxidase; Polyarteritis Nodosa; Ribonucleosides; Ticlopidine; Vasculitis, Leukocytoclastic, Cutaneous; Warfarin

2010
Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature.
    Modern rheumatology, 2013, Volume: 23, Issue:3

    Topics: Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Humans; Immunosuppressive Agents; Middle Aged; Otitis Media; Peroxidase; Ribonucleosides; Treatment Outcome

2013

Trials

1 trial(s) available for mizoribine and mocetinostat

ArticleYear
The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring.
    Clinical and experimental nephrology, 2022, Volume: 26, Issue:11

    Topics: Adrenal Cortex Hormones; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Humans; Immunosuppressive Agents; Peroxidase; Ribonucleosides

2022

Other Studies

6 other study(ies) available for mizoribine and mocetinostat

ArticleYear
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Autoimmune Diseases; Biopsy, Needle; Combined Modality Therapy; Dipyridamole; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Neutrophils; Peroxidase; Plasmapheresis; Prednisolone; Ribonucleosides; Scleroderma, Systemic

1997
[Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Nihon Jinzo Gakkai shi, 2000, Volume: 42, Issue:5

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Combined Modality Therapy; Drug Therapy, Combination; Glomerulonephritis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Male; Methylprednisolone; Peroxidase; Plasma; Plasma Exchange; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome

2000
Mizoribine for crescentic glomerulonephritis with sarcoidosis: effectiveness not only for urinalysis abnormalities but also for hilar lymph node enlargement.
    Modern rheumatology, 2013, Volume: 23, Issue:1

    Topics: Antibodies, Antineutrophil Cytoplasmic; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Function Tests; Lymph Nodes; Lymphatic Diseases; Middle Aged; Peroxidase; Prednisolone; Radiography, Thoracic; Ribonucleosides; Sarcoidosis; Treatment Outcome; Urinalysis

2013
Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizorib
    Microbiology and immunology, 2013, Volume: 57, Issue:9

    Topics: Animals; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Chemokine CCL2; Disease Models, Animal; Female; Glomerulonephritis; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Peroxidase; Receptors, Interleukin-6; Ribonucleosides; T-Lymphocyte Subsets

2013
A case of microscopic polyangiitis with skin manifestations in a seven-year-old girl.
    Dermatology online journal, 2013, Sep-14, Volume: 19, Issue:9

    Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantigens; Child; Female; Hemorrhage; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Microscopic Polyangiitis; Peroxidase; Prednisolone; Recurrence; Ribonucleosides; Skin; Tomography, X-Ray Computed; Vasculitis, Leukocytoclastic, Cutaneous

2013
A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchang
    CEN case reports, 2020, Volume: 9, Issue:1

    Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Asian People; Autoantibodies; Combined Modality Therapy; Female; Glucocorticoids; Hemorrhage; Humans; Immunosuppressive Agents; Lung Diseases; Peroxidase; Plasma Exchange; Prednisolone; Remission Induction; Renal Dialysis; Ribonucleosides; Treatment Outcome

2020